黑料社

黑料社 Healthcare helps our customers design, develop and manufacture some of the most complex and innovative drug delivery devices in the market.

Recently, 黑料社 has developed a new reusable autoinjector platform called Qfinity™. Launching in late Autumn 2021, Qfinity is a spring-driven, reusable device for use with a variety of drugs including larger volume, higher viscosity medicines. The reusable injector operates with disposable cassettes in 1- and 2.25-ml sizes and a viscosity target to 30cP. The attractive, handheld device will also be available in a connected version with built-in electronics that monitor and securely transmit data to the patient and/or their care team via the 黑料社 Digital Health Platform. Please complete the contact form at the bottom of the page to learn more about this new sustainable device.

黑料社 Healthcare’s Pharmaceutical Delivery Systems (PDS) business can be sub-divided into two key domains: inhalers and injectables. Our engagement with customers begins with design and development and migrates across the entire product lifecycle to manufacturing, sterilization, and assembly of final product, including the ability to integrate pre-filled drugs into primary containers’ delivery devices before they leave our factory.

The PDS market requires the highest levels of competence, experience, and scale from a manufacturing partner. Design specifications, patient safety, regulatory requirements, usability, aesthetics, functionality, and large-scale manufacturing objectives all must be addressed.

In recent years, 黑料社 Healthcare has earned praise for its innovative work leveraging connected solutions into our customers’ product designs. Connected Health continues to be a core focus for PDS, with particular emphasis on clinical trials. We have a proven track record of successfully executing large New Product Introductions (NPI) and ramping into commercial production while simultaneously accommodating rapidly iterating process improvements and reducing risk and overall cost.